高级检索
刘杰, 朱丽萍, 杨旭丽, 徐艳, 颜玮, 陈轶英. 江西省肿瘤登记地区2010 — 2017年恶性肿瘤流行情况[J]. 中国公共卫生, 2018, 34(12): 1692-1695. DOI: 10.11847/zgggws1120543
引用本文: 刘杰, 朱丽萍, 杨旭丽, 徐艳, 颜玮, 陈轶英. 江西省肿瘤登记地区2010 — 2017年恶性肿瘤流行情况[J]. 中国公共卫生, 2018, 34(12): 1692-1695. DOI: 10.11847/zgggws1120543
Jie LIU, Li-ping ZHU, Xu-li YANG, . Incidence, mortality and life lost of malignancies among residents living in areas covered by cancer registry in Jiangxi province, 2010 – 2017[J]. Chinese Journal of Public Health, 2018, 34(12): 1692-1695. DOI: 10.11847/zgggws1120543
Citation: Jie LIU, Li-ping ZHU, Xu-li YANG, . Incidence, mortality and life lost of malignancies among residents living in areas covered by cancer registry in Jiangxi province, 2010 – 2017[J]. Chinese Journal of Public Health, 2018, 34(12): 1692-1695. DOI: 10.11847/zgggws1120543

江西省肿瘤登记地区2010 — 2017年恶性肿瘤流行情况

Incidence, mortality and life lost of malignancies among residents living in areas covered by cancer registry in Jiangxi province, 2010 – 2017

  • 摘要:
      目的   分析江西省2010 — 2017年肿瘤登记地区恶性肿瘤的发病与死亡情况。
      方法   利用江西省国家级肿瘤登记处上报的数据,计算恶性肿瘤发病(死亡)率、标化率、潜在减寿年数(PYLL)、潜在减寿率(PYLLR)、平均减寿年数(AYLL)及寿命损失年(YLL)等指标。
      结果   江西省肿瘤登记地区恶性肿瘤粗发病率为204.43/10万,标化率为167.49/10万;发病率男性高于女性(P < 0.01),城市发病率高于农村(P < 0.01)。恶性肿瘤粗死亡率为125.68/10万,标化率为99.87/10万;男性死亡率高于女性(P < 0.01),农村死亡率高于城市(P < 0.01)。江西省肿瘤登记地区居民恶性肿瘤PYLL为382 977人年,PYLLR为27.42 ‰,AYLL为11.14年。导致居民过早死亡的前5位癌症依次为肝癌、肺癌、胃癌、结直肠癌和白血病。AYLL位居前2位的依次为白血病和肝癌,分别为23.56年和14.47年。2010 — 2017年,女性恶性肿瘤发病率表现为相对平稳,而女性恶性肿瘤死亡率变化趋势表现为先上升后下降趋势(P < 0.05)。
      结论  肺癌、肝癌、胃癌、结直肠癌、食管癌和女性乳腺癌及宫颈癌为江西省的主要癌症,癌症流行在不同性别之间存在差异,应针对重点癌症加强综合防控工作。

     

    Abstract:
      Objective  To analyze the incidence and mortality of malignancies among the residents living in the areas covered by cancer registry in Jiangxi province between 2010 and 2017.
      Methods  We collected the data of 2010 – 2017 on population, incidence and mortality of malignancies, and death registration for populations in 12 counties or districts covered by the National Cancer Registry in Jiangxi province. Then we calculated the incidence, mortality, age-standardized rate of malignancies and potential years of life lost (PYLL), potential years of life lost rate (PYLLR), average years of life lost (AYLL), and years of life lost (YLL) due to malignancies during the 8-year period in the 12 regions.
      Results  For the 12 regions during the period, the crude incidence rate of malignancy was 204.43/100 000 and the age standardized incidence rate by Chinese standard population in 2000 (ASIRC) was 167.49/100 000; the incidence rate was significantly higher in the males than in the females (P < 0.01) and higher in urban regions than in rural regions (P < 0.01). The crude mortality rate of malignancies was 125.68/100 000 and age standardized mortality rate by Chinese standard population in 2000 (ASMRC) was 99.87/100 000; the mortality rate was higher in the males than in the females (P < 0.01) and higher in rural regions than in urban regions (P < 0.01). The figures of life lost due to malignancies were 382 977 person-years for PYLL, 27.42‰ for PYLLR, and 11.14 years for AYLL, respectively. The top five malignancies causing premature deaths of the residents were liver, lung, stomach, colorectal cancer and leukemia. The top two malignancies resulting higher AYLLs were leukemia (23.56 years) and liver cancer (14.47) years. During the period in the females, the incidence rate of malignancies was relatively stable (P > 0.05), while the mortality of malignancies increased first and then decreased (P < 0.05).
      Conclusion  In regions covered by National Cancer Registry in Jiangxi province, malignancies of lung, liver, stomach, colorectum, and esophagus are main cancers among general population and breast and cervical cancer are the main cancers in female residents and there are gender differences in the prevalence of the malignancies in populations in these regions. The results should be concerned in cancer control.

     

/

返回文章
返回